Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio By Aydin H. Harston on July 28, 2021 Posted in Trends & Analysis On July 27, 2021, Amgen announced that it will acquire Bay area-based Teneobio, a privately held, clinical stage biotechnology… Continue Reading Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio